RLAYRelay Therapeutics, Inc.
$18.17+179% 1Y
$18.17
$6.0552 weeks$20.77
Is the price fair?
What RLAY's price assumes
Relay Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 385× revenue.
385
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 4.47
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 376
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 4.47
- EV / EBIToperating margin −2999%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 376
- Market capitalisation219.1 million shares, counted Jul 31, 2026
- $3.98B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks